MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBC

Conditions:   Breast Neoplasm;   Brain Metastases;   Triple Negative Breast Cancer;   HER2-positive Breast Cancer Intervention:   Diagnostic Test: MRI screening Sponsors:   Sunnybrook Health Sciences Centre;   Harvard University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials